Encouraging Signs For Arcus In TIGIT Race, But Gilead Holds Fire
Triplet Might Offer Arcus An Edge
Arcus Biosciences has one of the most advanced TIGIT programs, but early data were not strong enough to convince partner Gilead to commit to funding pivotal studies just yet
